ÐÓ°ÉÖ±²¥

Leadership 3, 2023-2027
N-3 (Omega-3) Precision Nutrition: Preventing prematurity and enhancing cognitive development of very preterm children.

Leadership 3, 2022-2026
Restoring the Fair Go: which policies and practices are likely to reverse growing health inequities in ÐÓ°ÉÖ±²¥ post COVID-19.

Leadership 3, 2022-2026
A curative approach for chronic myeloid leukaemia.

Leadership 3, 2020-2024
Gastric emptying, glucagon-like peptide-1 and glycaemic control in diabetes and critical illness.

Leadership 3, 2020-2024
Understanding and preventing pneumococcal disease.

Leadership 2, 2025-2029
Novel Strategies for Global Control of Meningococcal Disease and Gonorrhoea.

Leadership 2, 2025-2029
Exploring the Boundaries of Nuclear Reprogramming.

Leadership 2, 2023-2027
Managing the First Pillar for Atrial Fibrillation and Stroke.

Leadership 2, 2022-2026
Advancing Indigenous ÐÓ°ÉÖ±²¥n Oral health through clinical trials, cohort studies and surveillance.

Leadership 2, 2021-2025
Healthy diet and weight management in pregnancy: evidence to ease a hefty clinical burden.

Leadership 2, 2021-2025, NHMRC Elizabeth Blackburn Investigator Grant Award
Peri-conception determinants of reproductive and pregnancy health.

Leadership 2, 2021-2025
From bench to bedside: A new treatment for chronic rhinosinusitis.

Leadership 1, 2026-2030
Advancing the Science of Evidence Synthesis: Developing Standards, Guidance and Resources for Better Evidence for Better Health Decisions. 

Leadership 1, 2025-2029
Supporting Neurodevelopment through Targeted Nutrition.

Leadership 1, 2022-2026
Novel nanotechnology strategies towards a new paradigm of precision nanomedicine.

Emerging Leadership 2, 2025-2029
Harnessing the Gut Microbiota to Predict and Prevent Life-Threatening Complications of Blood Cancer Treatment.

Emerging Leadership 2, 2024-2028
New approaches to the prevention and management of heart rhythm disorders.

Emerging Leadership 2, 2022-2026
Addressing evidence gaps to improve adolescent sexual and reproductive health.

Emerging Leadership 2, 2021-2025
Driving advances in sugar-sweetened beverage policy and resolving the unknown substitution effects into artificially sweetened beverage, fruit juice and water consumption.

Professor Philippa Middleton
Emerging Leadership 2, 2020-2024
Implementing nutrition and lifestyle interventions for women, young children and families.

Emerging Leadership 1, 2025-2029
Innovative Chemoimmunotherapy for Metastatic Castration-Resistant Prostate Cancer.

Emerging Leadership 1, 2025-2029
Systematic Reviews of Aetiology and Risk Factors of Disease: A Program of Methodological Research.

Emerging Leadership 1, 2024-2028
A conductive hydrogel-based cardiac patch integrated with bioelectronics for repairing infarcted myocardium.

Emerging Leadership 1, 2023-2027
Sickly sweet: managing high blood glucose during and post critical illness.

Emerging Leadership 1, 2022-2026
Developing Genetic Testing Tools for Optimising Pharmacotherapy and Enabling a Precision Mental Health Care.

Emerging Leadership 1, 2022-2026
Developing more accurate cardiovascular disease detection with a cellular-resolution imaging catheter.

Emerging Leadership 1, 2022-2026
Preterm birth and neurodevelopment: improving long-term outcomes.

Doctor Roula Ghaoui
Emerging Leadership 1, 2021-2025
Diagnosing hereditary myopathies and dystrophies with RNA sequencing: translating research innovations into diagnostic practice.

Emerging Leadership 1, 2021-2025
Improving the Synthesis of Medical Research: The Evidence Synthesis Taxonomy Initiative.

Emerging Leadership 1, 2020-2024
Improving wellbeing and preventing lateral violence in the Aboriginal community in SA: Investing in our young.

Emerging Leadership 1, 2020-2024
Increasing the value of randomised trials: a combined program of methodological and applied health research.